Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Different Doses of CB03-154 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial to evaluate the efficacy and safety of different doses of CB03-154 in adults with Amyotrophic Lateral Sclerosis; the study is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• CB03-154

Snippet

Sponsor: Shanghai Zhimeng Biopharma, Inc. | Conditions: ALS (Amyotrophic Lateral Sclerosis) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING